Hologic to buy VC-backed Focal Therapeutics for $125 mln
Hologic has agreed to acquire Sunnyvale, California-based Focal Therapeutics, a medical device company, for $125 million. Focal Therapeutics was backed by Okapi Venture Capital and Emergent Medical Partners, according to Crunchbase.
1 October 2018•3 mins read
